Literature DB >> 25337303

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2014 MauiDerm Meeting.

Neal Bhatia1, Andrew Blauvelt2, Marc Brown3, Whitney High4, Craig T Leonardi5, Ted Rosen6, Linda Stein Gold7, Eggert Stockfleth8, Bruce Strober9, Neil A Swanson10, George Martin11.   

Abstract

Entities:  

Year:  2014        PMID： 25337303      PMCID： PMC4204446     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


× No keyword cloud information.
  112 in total

Review 1.  Squamous cell carcinoma arising in a nevus sebaceous of Jadassohn in a 9-year-old girl: treatment using Mohs micrographic surgery with literature review.

Authors:  Muba Taher; Cary Feibleman; Richard Bennett
Journal:  Dermatol Surg       Date:  2010-06-01       Impact factor: 3.398

2.  Successful treatment of disseminated superficial actinic porokeratosis with calcipotriol.

Authors:  Ilko Bakardzhiev; Svetlana Kavaklieva; Georgy Pehlivanov
Journal:  Int J Dermatol       Date:  2011-07-05       Impact factor: 2.736

3.  Psoriasis Epidemiology Screening Tool (PEST): a report from the GRAPPA 2009 annual meeting.

Authors:  Philip S Helliwell
Journal:  J Rheumatol       Date:  2011-03       Impact factor: 4.666

4.  Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.

Authors:  Bernd Kasper; Dominique Lossignol; Thierry Gil; Patrick Flamen; Nicolas De Saint Aubain; Ahmad Awada
Journal:  Anticancer Drugs       Date:  2006-11       Impact factor: 2.248

5.  Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.

Authors:  Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-10       Impact factor: 10.282

6.  Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.

Authors:  K A Papp; C E M Griffiths; K Gordon; M Lebwohl; P O Szapary; Y Wasfi; D Chan; M-C Hsu; V Ho; P D Ghislain; B Strober; K Reich
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

7.  Depression and anxiety in psoriatic disease: prevalence and associated factors.

Authors:  Emily McDonough; Renise Ayearst; Lihi Eder; Vinod Chandran; Cheryl F Rosen; Arane Thavaneswaran; Dafna D Gladman
Journal:  J Rheumatol       Date:  2014-04-01       Impact factor: 4.666

8.  A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.

Authors:  A B Gottlieb; R G Langley; B E Strober; K A Papp; P Klekotka; K Creamer; E H Z Thompson; M Hooper; G Kricorian
Journal:  Br J Dermatol       Date:  2012-09       Impact factor: 9.302

9.  Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.

Authors:  Mayte Suárez-Fariñas; Katherine Li; Judilyn Fuentes-Duculan; Karen Hayden; Carrie Brodmerkel; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551

10.  The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis.

Authors:  Laura C Coates; Nuria Navarro-Coy; Sarah R Brown; Sarah Brown; Lucy McParland; Howard Collier; Emma Skinner; Jennifer Law; Anna Moverley; Sue Pavitt; Claire Hulme; Paul Emery; Philip G Conaghan; Philip S Helliwell
Journal:  BMC Musculoskelet Disord       Date:  2013-03-21       Impact factor: 2.362
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.